Monday, September 30, 2013

• pSivida Announces That U.K.’s NICE Recommends ILUVIEN® for Chronic Diabetic Macular Edema in Pseudophakic Eyes; NHS Reimbursement Expected to FollowBusiness Wire( (Mon, Sep 30)

Friday, September 27, 2013

• pSivida to Present at 4th Annual Conference on Biosimilars & BiobettersBusiness Wire( (Fri, Sep 27)

Wednesday, September 25, 2013

• pSivida Corp. Reports Fourth Quarter and Fiscal Year 2013 ResultsBusiness Wire( (Wed, Sep 25)

Wednesday, September 18, 2013

• pSivida Corp. Announces Fourth Quarter and Fiscal Year 2013 Financial Results Release Date and Conference Call InformationBusiness Wire( (Wed, Sep 18)

Wednesday, September 4, 2013

• pSivida to Present At Two Investment Conferences in SeptemberBusiness Wire( (Wed, Sep 4)

Monday, August 5, 2013

• pSivida Corp - Sustained Release Biologics: The Missing PieceAccesswire( (Mon, Aug 5)

Monday, July 29, 2013

• pSivida CEO to Discuss Sustained Delivery of Antibodies in Ophthalmology and Systemic Disease at International Symposium on Integrated FunctionalitiesBusiness Wire( (Mon, Jul 29)

Wednesday, July 24, 2013

• pSivida Announces France’s Transparency Commission Issues Positive Opinion for Reimbursement of ILUVIENBusiness Wire( (Wed, Jul 24)

Friday, July 19, 2013

• pSivida Announces Pricing of $10.8 Million Offering of Common StockBusiness Wire( (Fri, Jul 19)

Thursday, July 18, 2013

• pSivida Announces Proposed Public Offering of Common StockBusiness Wire( (Thu, Jul 18)

Thursday, July 11, 2013

• pSivida Corp. Announces Interim Data From Investigator-Sponsored Uveitis StudyBusiness Wire( (Thu, Jul 11)

Monday, July 1, 2013

• pSivida Corp. Announces Initiation of Phase III Clinical Trial in Posterior UveitisBusiness Wire( (Mon, Jul 1)

Friday, June 14, 2013

• pSivida Corp. Announces UK’s NICE Says Yes to ILUVIEN® in Some Patients with Diabetic Macular Edema in New Draft GuidanceBusiness Wire( (Fri, Jun 14)